Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Hodgkin Disease × CTLA-4 Antigen × 30 days × Clear all

Sponsor

Conditions

Melanoma 5 Carcinoma, Renal Cell 4 Urinary Bladder Neoplasms 3 Urethral Neoplasms 3 Neoplasm Metastasis 3 Urogenital Neoplasms 2 Ureteral Neoplasms 2 Prostatic Neoplasms 2 Penile Neoplasms 2 Lung Neoplasms 2 Carcinoma, Transitional Cell 2 Carcinoma, Non-Small-Cell Lung 2 Carcinoma, Endometrioid 2 Carcinoma, Basal Cell 2 Vulvar Neoplasms 1 Urachal adenocarcinoma 1 Thyroid Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Somatostatinoma 1 Small Cell Lung Carcinoma 1 Seminoma 1 Rectal Neoplasms 1 Rare Diseases 1 Pseudomyxoma Peritonei 1 Pheochromocytoma 1 Perivascular Epithelioid Cell Neoplasms 1 Parathyroid Neoplasms 1 Paranasal Sinus Neoplasms 1 Paraganglioma 1 Paget Disease, Extramammary 1

Interventions

Cyclophosphamide 9 fludarabine phosphate 5 fludarabine 5 Magnetic Resonance Spectroscopy 4 Filgrastim 4 Etoposide 4 Doxorubicin 4 Vincristine 3 Vinblastine 3 Rituximab 3 Prednisone 3 Nivolumab 3 Gemcitabine 3 Dacarbazine 3 Bleomycin 3 pembrolizumab 2 Specimen Handling 2 Radiotherapy 2 Prednisolone 2 Mycophenolic Acid 2 Mesna 2 Melphalan 2 Lenalidomide 2 Granulocyte Colony-Stimulating Factor 2 Cisplatin 2 Brentuximab Vedotin 2 Blood Specimen Collection 2 treosulfan 1 tislelizumab 1 thymoglobulin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡